- Home
- KPLT vs LUCD Comparison
KPLT vs LUCD Comparison
Compare KPLT & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KPLT | LUCD |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 132.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | KPLT | LUCD |
|---|---|---|
| Price | $6.91 | $1.07 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $10.00 | $3.94 |
| AVG Volume (30 Days) | ★ 1.1M | 701.5K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $280,839,000.00 | $4,399,000.00 |
| Revenue This Year | $21.42 | $11.18 |
| Revenue Next Year | $15.48 | $147.43 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 16.15 | 5.01 |
| 52 Week Low | $5.08 | $0.75 |
| 52 Week High | $24.34 | $1.80 |
Technical Indicators
Market Signals| Indicator | KPLT | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 44.21 |
| Support Level | $6.24 | $1.09 |
| Resistance Level | $6.80 | $1.15 |
| Average True Range (ATR) | 0.57 | 0.05 |
| MACD | 0.22 | -0.00 |
| Stochastic Oscillator | 28.79 | 0.00 |
Price Performance
Historical ComparisonAbout KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.